GO:0034059

BP

response to anoxia

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating a decline in oxygen levels to trace amounts, <0.1%.

CTGF, OXTR

GO:0034063

BP

stress granule assembly

The aggregation, arrangement and bonding together of proteins and RNA molecules to form a stress granule.

DDX3X, CIRBP, DYNC1H1, PUM2, ATXN2L, BICD1

GO:0034067

BP

protein localization to Golgi apparatus

A process in which a protein is transported to, or maintained in, a location within the Golgi apparatus.

OBSL1, CSNK1D, GBF1

GO:0034080

BP

CENP-A containing nucleosome assembly

The formation of nucleosomes containing the histone H3 variant CENP-A to form centromeric chromatin. This specialised chromatin occurs at centromeric region in point centromeres, and the central core in modular centromeres.

STRA13, OIP5, SMARCA5, NPM1, CENPA, HIST1H4A, CENPC, RBBP4, ITGB3BP, CENPW, MIS18BP1, CENPU, CENPQ, CENPL, APITD1, HJURP, CASC5, CENPN, RSF1, CENPK, CENPO, CENPH, CENPM, MIS18A, RUVBL1

GO:0034088

BP

maintenance of mitotic sister chromatid cohesion

The process in which the association between sister chromatids of a replicated chromosome is maintained as chromosomes condense, attach to the spindle in a bipolar orientation, and congress to the metaphase plate during a mitotic cell cycle.

RB1, NIPBL, DSCC1

GO:0034097

BP

response to cytokine

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.

PTGES, ALDH1A2, TIMP1, FOS, COL3A1, TYMS, JUN, IL6R, SPARC, BCL2, SKIL, FOSL1, TIMP2, JUNB, JUND, AVPR2, OXTR, DDOST, PLA2G5, IL6ST, LIFR, MAPKAPK2, PGGT1B, RELB, REL, MCL1, OSMR, CITED1, CXCL16, TNFRSF11A

GO:0034101

BP

erythrocyte homeostasis

Any process of regulating the production and elimination of erythrocytes within an organism.

GPI, RPS17, HMOX1, AMPD3, PRDX1

GO:0034103

BP

regulation of tissue remodeling

Any process that modulates the frequency, rate, or extent of tissue remodeling.

CST3, THBS4

GO:0034104

BP

negative regulation of tissue remodeling

Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling.

AGT

GO:0034105

BP

positive regulation of tissue remodeling

Any process that activates or increases the frequency, rate, or extent of tissue remodeling.

IL18

GO:0034109

BP

homotypic cell-cell adhesion

The attachment of a cell to a second cell of the identical type via adhesion molecules.

PLPP3, MEGF10

GO:0034111

BP

negative regulation of homotypic cell-cell adhesion

Any process that stops, prevents, or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.

RDX

GO:0034112

BP

positive regulation of homotypic cell-cell adhesion

Any process that activates or increases the frequency, rate, or extent of homotypic cell-cell adhesion.

TNFSF11, CCL5, ANK3

GO:0034113

BP

heterotypic cell-cell adhesion

The attachment of a cell to a cell of a different type via adhesion molecules.

ITGB3, ITGB2, ITGB1, ITGAV, ITGA5, CD1D, CD58, ITGAX, GLDN, NRCAM, PERP, PARVA

GO:0034115

BP

negative regulation of heterotypic cell-cell adhesion

Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.

KLF4, APOA1, IL1RN, IL10, MAP2K5, MAPK7, ADIPOQ, MYADM

GO:0034116

BP

positive regulation of heterotypic cell-cell adhesion

Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.

FLOT1, TNF, IL1B, FGA, FGB, FGG, ALOX15, CD44, IL10, GCNT2

GO:0034120

BP

positive regulation of erythrocyte aggregation

Any process that activates or increases the frequency, rate, or extent of erythrocyte aggregation.

LGALS1

GO:0034121

BP

regulation of toll-like receptor signaling pathway

Any process that modulates the frequency, rate, or extent of toll-like receptor signaling pathway.

ESR1, BIRC3

GO:0034122

BP

negative regulation of toll-like receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor signaling pathway.

TYRO3, LGR4, NFKBIL1, IRAK3

GO:0034123

BP

positive regulation of toll-like receptor signaling pathway

Any process that activates or increases the frequency, rate, or extent of toll-like receptor signaling pathway.

TLR3, TLR5, TLR2

GO:0034124

BP

regulation of MyD88-dependent toll-like receptor signaling pathway

Any process that modulates the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.

IRF1

GO:0034128

BP

negative regulation of MyD88-independent toll-like receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-independent toll-like receptor signaling pathway.

TLR4, TLR3, CD14, SARM1

GO:0034130

BP

toll-like receptor 1 signaling pathway

Any series of molecular signals generated as a consequence of binding to toll-like receptor 1.

TLR1

GO:0034134

BP

toll-like receptor 2 signaling pathway

Any series of molecular signals generated as a consequence of binding to toll-like receptor 2.

RIPK2, TLR2, IRAK1

GO:0034136

BP

negative regulation of toll-like receptor 2 signaling pathway

Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 2 signaling pathway.

LYN, TNFAIP3

GO:0034137

BP

positive regulation of toll-like receptor 2 signaling pathway

Any process that activates or increases the frequency, rate, or extent of toll-like receptor 2 signaling pathway.

F2RL1, TIRAP

GO:0034138

BP

toll-like receptor 3 signaling pathway

Any series of molecular signals generated as a consequence of binding to toll-like receptor 3.

TLR3, RFTN1, COLEC12

GO:0034140

BP

negative regulation of toll-like receptor 3 signaling pathway

Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 3 signaling pathway.

TNFAIP3, F2RL1

GO:0034141

BP

positive regulation of toll-like receptor 3 signaling pathway

Any process that activates or increases the frequency, rate, or extent of toll-like receptor 3 signaling pathway.

FLOT1, F2RL1, TIRAP, CAV1, PELI1, PTPN22

GO:0034142

BP

toll-like receptor 4 signaling pathway

Any series of molecular signals generated as a consequence of binding to toll-like receptor 4.

TLR4, RIPK2, ITGB2, CD14, ITGAM, IRAK1, TIRAP, NR1H4

GO:0034144

BP

negative regulation of toll-like receptor 4 signaling pathway

Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 4 signaling pathway.

LYN, NR1D1, TNFAIP3, BPIFB1

GO:0034145

BP

positive regulation of toll-like receptor 4 signaling pathway

Any process that activates or increases the frequency, rate, or extent of toll-like receptor 4 signaling pathway.

F2RL1, TIRAP, NR1H3, PELI1, PTPN22

GO:0034146

BP

toll-like receptor 5 signaling pathway

Any series of molecular signals generated as a consequence of binding to toll-like receptor 5.

TLR5

GO:0034148

BP

negative regulation of toll-like receptor 5 signaling pathway

Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 5 signaling pathway.

TNFAIP3

GO:0034162

BP

toll-like receptor 9 signaling pathway

Any series of molecular signals generated as a consequence of binding to toll-like receptor 9.

IRAK2, IRAK1, PIK3C3, NR1H4, PIK3R4

GO:0034165

BP

positive regulation of toll-like receptor 9 signaling pathway

Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway.

HMGB1

GO:0034184

BP

positive regulation of maintenance of mitotic sister chromatid cohesion

Any process that increases the extent to which the association between sister chromatids of a replicated chromosome is maintained during a mitotic cell cycle.

H2AFY, SLF2, SMC5, SLF1

GO:0034197

BP

triglyceride transport

The directed movement of triglyceride into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.

APOH, CD36, VAMP7

GO:0034198

BP

cellular response to amino acid starvation

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids.

DAPL1, EIF2S1, ATF3, ATF4, CDKN1A, DAP, UCP2, NPRL3, RNF152, GCN1, SEH1L, RRAGC, EIF2AK4, IMPACT, SH3GLB1

GO:0034199

BP

activation of protein kinase A activity

Any process that initiates the activity of the inactive enzyme protein kinase A.

ADCY3, ADCY9, PRKAR1A, PRKAR2A, PRKACA, PRKAR2B, ADCY7

GO:0034201

BP

response to oleic acid

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oleic acid stimulus.

ACSL1, AACS, BAD

GO:0034205

BP

beta-amyloid formation

The generation of beta-amyloid by cleavage of the amyloid precursor protein (APP).

PSEN1

GO:0034213

BP

quinolinate catabolic process

The chemical reactions and pathways resulting in the breakdown of quinolinate, the anion of quinolinic acid, also known as 2,3-pyridinedicarboxylic acid.

QPRT

GO:0034214

BP

protein hexamerization

The formation of a protein hexamer, a macromolecular structure consisting of six noncovalently associated identical or nonidentical subunits.

MAT2A, VCP, PANX2, PANX1, PEO1, SPAST

GO:0034219

BP

carbohydrate transmembrane transport

The process in which a carbohydrate is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.

SLC35E1

GO:0034220

BP

ion transmembrane transport

A process in which an ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.

FXYD1, KCNK3, ATP6V0E1, ATP8B1, ATP6V1G1, BEST1, AQP8, ATP6V1G2, RAF1, ATP1B1, S100A6, ANXA6, UBC, ATP2A2, GJA1, ATP2B1, ATP6V1B2, ATP6V1C1, ATP2B4, MIP, GABRA5, GJC1, CHRNA7, SCNN1A, AQP2, GRIA4, GLRB, ATP1A2, SCNN1G, CLCN4, CLCN5, CLCN6, CLCN7, CLCNKA, CLCNKB, ATP12A, ATP1B3, FXYD4, ATP6V0D1, NCALD, CALM2, RPS27A, UBA52, DLG4, ATP2C1, ASPH, DLG1, TCIRG1, CLCA4, RYR3, ASIC2, ATP6V1F, CHRFAM7A, ANO6, ATP13A5, PDZD11, FAM26F, SFXN4, OSTM1, ATP6V1C2, TPCN2, AQP3, RYR2, ATP6V0A1, SGK3, NEDD4L, P2RX4, TSC22D3, SFXN3, WWP1, TTYH1, SFXN1, CALHM2, ATP13A2, ANO2, ASIC3, ATP6V1H, ATP11B, ATP6V1D

GO:0034224

BP

cellular response to zinc ion starvation

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of zinc ions.

SLC39A4

GO:0034241

BP

positive regulation of macrophage fusion

Any process that activates or increases the frequency, rate or extent of macrophage fusion.

ADAM9

GO:0034243

BP

regulation of transcription elongation from RNA polymerase II promoter

Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.

ZMYND11

GO:0034244

BP

negative regulation of transcription elongation from RNA polymerase II promoter

Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.

AXIN1, RNF8, EZH2

GO:0034255

BP

regulation of urea metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving urea.

NR1H4

GO:0034260

BP

negative regulation of GTPase activity

Any process that stops or reduces the rate of GTP hydrolysis by a GTPase.

IPO5, RASA4, SPRY2, SPRY1, PDE6D, SLIT2, RDX, IQGAP1, TNK2, GPS2, IQGAP2, TMED2, RGN, AMOT, CPEB2, FICD, MKKS, CDC42SE1, SH3BP4, F11R

GO:0034263

BP

autophagy in response to ER overload

The process in which cells digest parts of their own cytoplasm in response to the accumulation of misfolded proteins in the endoplasmic reticulum.

ATG10

GO:0034314

BP

Arp2/3 complex-mediated actin nucleation

The actin nucleation process in which actin monomers combine to form a new branch on the side of an existing actin filament; mediated by the Arp2/3 protein complex and its interaction with other proteins.

WASH1, ARPC2, ARPC3, ARPC4, ACTR3, ACTR2, IQGAP2, JMY

GO:0034315

BP

regulation of Arp2/3 complex-mediated actin nucleation

Any process that modulates the frequency, rate or extent of actin nucleation mediated by the Arp2/3 complex and interacting proteins.

ARFIP1, ARF1, CORO1B

GO:0034316

BP

negative regulation of Arp2/3 complex-mediated actin nucleation

Any process that stops, prevents, or reduces the frequency, rate or extent of actin nucleation mediated by the Arp2/3 complex and interacting proteins.

CORO1B

GO:0034329

BP

cell junction assembly

A cellular process that results in the aggregation, arrangement and bonding together of a set of components to form a cell junction.

FLNA, LIMS1, ACTB, ACTG1, ILK, FLNC, FBLIM1, VMP1

GO:0034332

BP

adherens junction organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.

CTNND1, ANG, JUP, PVR, DSP, CDH2, CDH5, CTNNA1, CSK, NUMB, CDH6, CDH11, CDH12, CDH13, CDH15, CDC42, CDH17, NECTIN1, RAB8B, CADM1, NECTIN3

GO:0034333

BP

adherens junction assembly

The aggregation, arrangement and bonding together of a set of components to form an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.

SMAD7, PIP5K1C, JUP, CTNNB1, TBCD

GO:0034334

BP

adherens junction maintenance

The maintenance of an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.

RASSF8, PKP2

GO:0034340

BP

response to type I interferon

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a type I interferon stimulus. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

ISG15, SP100

GO:0034341

BP

response to interferon-gamma

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon.

UBD, CYP27B1, IFITM1, SP100, SNCA, SLC11A1, SEC61A1, IFITM3, BST2, CALCOCO2, KYNU, SLC30A8, CITED1, CXCL16, NUB1

GO:0034346

BP

positive regulation of type III interferon production

Any process that activates or increases the frequency, rate, or extent of type III interferon production. Interferon lambda is the only member of the type III interferon found so far.

TLR3

GO:0034349

BP

glial cell apoptotic process

Any apoptotic process in a glial cell, a non-neuronal cell of the nervous system.

RB1, CASP9, BID

GO:0034351

BP

negative regulation of glial cell apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of glial cell apoptotic process.

CCL2, PRKCA, PRKCI, PRKCD

GO:0034354

BP

de novo' NAD biosynthetic process from tryptophan

The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of tryptophan from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH.

KMO, KYNU

GO:0034356

BP

NAD biosynthesis via nicotinamide riboside salvage pathway

The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD) from the vitamin precursor nicotinamide riboside.

PNP

GO:0034369

BP

plasma lipoprotein particle remodeling

The acquisition, loss or modification of a protein or lipid within a plasma lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the esterification of cholesterol by phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT).

APOC1

GO:0034370

BP

triglyceride-rich lipoprotein particle remodeling

The acquisition, loss or modification of a protein or lipid within a triglyceride-rich lipoprotein particle, including the hydrolysis of triglyceride by lipoprotein lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride from a triglyceride-rich lipoprotein particle.

APOA2, APOA5

GO:0034371

BP

chylomicron remodeling

The acquisition, loss or modification of a protein or lipid within a chylomicron, including the hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid.

LPL

GO:0034372

BP

very-low-density lipoprotein particle remodeling

The acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid.

APOE, LPL

GO:0034374

BP

low-density lipoprotein particle remodeling

The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.

AGT, APOE, APOA2, APOB, MPO, PLA2G2A, AGTR1, PLA2G7

GO:0034375

BP

high-density lipoprotein particle remodeling

The acquisition, loss or modification of a protein or lipid within a high-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.

APOA1, APOE, APOA2, APOC1, APOC3, SCARB1, ABCA5, LIPG

GO:0034379

BP

very-low-density lipoprotein particle assembly

The aggregation and arrangement of proteins and lipids in the liver to form a very-low-density lipoprotein particle.

APOC1, APOC3, APOB, SOAT1, ARF1

GO:0034380

BP

high-density lipoprotein particle assembly

The aggregation and arrangement of proteins and lipids to form a high-density lipoprotein particle.

ABCA1, APOA1, APOE, APOA2, APOA5

GO:0034381

BP

plasma lipoprotein particle clearance

The process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.

CD36

GO:0034382

BP

chylomicron remnant clearance

The process in which a chylomicron remnant is removed from the blood via receptor-mediated endocytosis into liver cells and its constituent parts degraded.

APOE, APOC1, APOC3, LMF1

GO:0034383

BP

low-density lipoprotein particle clearance

The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.

LDLR, APOB, HMOX1, CD36, ADIPOQ, SCARB1, DGAT2

GO:0034384

BP

high-density lipoprotein particle clearance

The process in which a high-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.

APOA1, APOE, APOA2, SCARB1

GO:0034389

BP

lipid particle organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lipid particle.

PPIA, PLIN5, PPID, RAB3GAP1, SPG20, PNPLA2, FAF2

GO:0034392

BP

negative regulation of smooth muscle cell apoptotic process

Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.

LRP6, APOH, IGF1, EDN1

GO:0034393

BP

positive regulation of smooth muscle cell apoptotic process

Any process that activates or increases the frequency, rate, or extent of smooth muscle cell apoptotic process.

IL12A, PDCD4, APOPT1

GO:0034394

BP

protein localization to cell surface

A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane.

FLNA, FGF7, CTNNB1, EMP2, ANK2, PTPRK, ANGPT1, MRAP, PIGK, MRAP2

GO:0034395

BP

regulation of transcription from RNA polymerase II promoter in response to iron

Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter in response to an iron stimulus.

HMOX1, SLC40A1

GO:0034402

BP

recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex

The process in which proteins required for 3'-end transcript processing become associated with the RNA polymerase II holoenzyme complex and the 3' end of a transcript.

POLR2D

GO:0034405

BP

response to fluid shear stress

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.

PDGFRB, GJA1, NOS3, AKT1, PKD1, P2RX4, CITED2

GO:0034418

BP

urate biosynthetic process

The chemical reactions and pathways resulting in the formation of urate, the anion of uric acid, 2,6,8-trioxypurine.

PNP, PRPS1

GO:0034421

BP

post-translational protein acetylation

The addition of an acetyl group to one or more amino acids in a protein, occurring after the protein has been completely translated and released from the ribosome.

ESCO2, DSCC1

GO:0034427

BP

nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'

The chemical reactions and pathways resulting in the breakdown of the mRNA transcript body that occurs when the 3' end is not protected by a 3'-poly(A) tail; degradation proceeds in the 3' to 5' direction.

EXOSC9, EXOSC2, EXOSC7, EXOSC6, EXOSC8, EXOSC4, EXOSC3

GO:0034435

BP

cholesterol esterification

A lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.

SOAT1

GO:0034436

BP

glycoprotein transport

The directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

VLDLR, GUK1

GO:0034440

BP

lipid oxidation

The removal of one or more electrons from a lipid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.

PLA2G7

GO:0034441

BP

plasma lipoprotein particle oxidation

The modification of a lipoprotein by oxidation of one or more amino acids or the lipid group, occurring in the blood plasma.

PLA2G7

GO:0034446

BP

substrate adhesion-dependent cell spreading

The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.

FZD7, FN1, ITGB3, ITGAV, LAMB1, LAMC1, EFNA1, RAB1A, RAC1, TEK, TYRO3, MERTK, ILK, KIF14, VAMP3, BVES, AKIP1, PARVA, FZD4

GO:0034447

BP

very-low-density lipoprotein particle clearance

The process in which a very-low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.

APOE, APOC1, VLDLR

GO:0034453

BP

microtubule anchoring

Any process in which a microtubule is maintained in a specific location in a cell.

PEX14, DAG1, PCM1, CEP57, FOPNL, CAMSAP3

GO:0034454

BP

microtubule anchoring at centrosome

Any process in which a microtubule is maintained in a specific location in a cell by attachment to a centrosome.

PCM1, HOOK3, NIN

GO:0034463

BP

90S preribosome assembly

The aggregation, arrangement and bonding together of proteins and RNA molecules to form a 90S preribosome. The 90S preribosome represents the complex that forms on the primary rRNA transcript before it splits into the small subunit and large subunit portions.

RPL38

GO:0034465

BP

response to carbon monoxide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbon monoxide (CO) stimulus.

IL10, KCNMA1

GO:0034473

BP

U1 snRNA 3'-end processing

Any process involved in forming the mature 3' end of a U1 snRNA molecule.

EXOSC9, EXOSC7, EXOSC8